Who owns Nektar Therapeutics?
Key information on Nektar Therapeutics (Ticker: NKTR)
- CUSIP: 640268108
Who owns Nektar Therapeutics?
Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.
- OppenheimerFunds owns 22.70M shares worth $249.70M
- HealthCor Management owns 10.81M shares worth $87.28M
- HealthCor Management owns 9.20M shares worth $66.88M
- PRIMECAP Management Company owns 7.05M shares worth $77.57M
- Vanguard owns 6.65M shares worth $73.16M
- Ulys owns 5.17M shares worth $28.93M
- GRANAHAN INVESTMENT MANAGEMENT INC/MA owns 2.84M shares worth $31.28M
- Artal Group S.A. owns 2.75M shares worth $30.25M
- Invus Public Equities Advisors owns 2.75M shares worth $19.99M
- BVF owns 2.73M shares worth $20.26M
- Barclays owns 2.71M shares worth $21.48M
- STATE STREET CORPORATION owns 2.67M shares worth $29.35M
- Deerfield Management Company owns 2.57M shares worth $28.23M
- NEA Management Company owns 1.83M shares worth $20.08M
- JPMORGAN CHASE & CO owns 1.79M shares worth $14.48M
- Millennium Management owns 1.73M shares worth $18.99M
- T. Rowe Price Associates owns 1.52M shares worth $16.72M
- First Trust Advisors owns 1.47M shares worth $16.15M
- ING Investment Management Co Address: 10 State House Square owns 1.40M shares worth $11.06M
- CITADEL ADVISORS owns 1.39M shares worth $10.30M
- CR Intrinsic Investors owns 1.32M shares worth $7.38M
- Legg Mason Capital Management owns 1.29M shares worth $10.37M
- Redmile owns 1.20M shares worth $9.65M
- Loomis, Sayles and owns 1.16M shares worth $12.41M
- Driehaus Capital Management owns 1.10M shares worth $11.70M
- Tang Capital Management owns 1.04M shares worth $11.49M
- Franklin Resources owns 1.03M shares worth $11.35M
- Perimeter Capital Partners owns 1.03M shares worth $5.74M
- Jefferies owns 1.01M shares worth $7.96M
- Hambrecht & Quist Capital Management owns 868474 shares worth $7.01M
- IronBridge Capital owns 853565 shares worth $9.39M
Who sold Nektar Therapeutics?
- Apex Capital sold on June 30, 2011
- ALLIANCEBERNSTEIN sold on March 31, 2011
- Columbia Wanger Asset Management sold on March 31, 2011
- Schroder Investment Management sold on March 31, 2011
- Name Passport Capital sold on March 31, 2011
- Renaissance Technologies sold on March 31, 2011
- CALAMOS ADVISORS sold on Dec. 31, 2010
- Wells Fargo & Company sold on Dec. 31, 2010
- Tudor Investment Corporation sold on Dec. 31, 2005
- Maverick Capital sold on Dec. 31, 2004
Funds that own NKTR also own:
- PNC Financial Services (PNC)
- Bank of America Corporation (BAC)
- Johnson & Johnson (JNJ)
- Vertex Pharmaceuticals Incorporated (VRTX)
- Edwards Lifesciences (EW)
- Kohl's Corporation (KSS)
- Newell Rubbermaid (NWL)
- Universal Health Services (UHS)
- Aetna (AET)
- PerkinElmer (PKI)
- Apple (AAPL)
- Baker Hughes Incorporated (BHI)
- UnitedHealth (UNH)
- Zimmer Holdings (ZMH)
- Mead Johnson Nutrition (MJN)
- Edison International (EIX)
- Humana (HUM)
- Cubist Pharmaceuticals (CBST)
- Nektar Therapeutics (NKTR)
- Rigel Pharmaceuticals (RIGL)
- Ariad Pharmaceuticals (ARIA)